Eiman Ibrahim, MD, MSc 🌺𓂀 🦋

I was honored to present at the @TIRO_expert-led tumor board, which brought together leaders in thyroid imaging, pathology, surgery, and endocrine care—moderated by Dr. Tuttle. Watch the full session: youtu.be/KALjTXPtO2k?si…

@HindHasssn_MD Best of luck 🤍🏆

#DDW2026 — Day 1 ✅ Excited for what’s next.

@DiabetologiaJnl Brilliant, thoughtful and definitely suitable for a May issue

Our May cover represents ageing with #T1D; the flowers remain luminous and resilient as they mature, but the location of the vase suggests a precarious equilibrium. In this issue, Maltese et al review the intersection between #T1D, ageing and frailty link.springer.com/article/10.100…

NEW pilot-grant program! 🔬 ATA is funding 15 early-career investigators with up to $10K for innovative thyroid research. Applications due May 15. Associate & Early Career Members—this is your opportunity! Apply: ow.ly/TRGv50YR6bF #ThyroidResearch #ResearchGrant #ATA

I’m pleased to announce that I received the @TheEndoSociety outstanding abstract award for the year 2026 on my project highlighting the Biochemical Activity and Metastatic Profile for patients with MEN2A with RET C609Y!! 🏆 📄 endocrine.org/awards/the-end…

@TheEndoSociety Thank you for having us! It was a great experience

We welcome 50 fellows to our first-ever Rare Disease Fellows Program! They will also be able to enjoy our pop-up store to bring home #endocrinology souvenirs. Many of these products will be sold at #ENDO2026, and in our online store: bit.ly/2PhQR98

Check out our latest article ⬇️📝

My work with @ADA_DiabetesPro, highlighting the barriers to inclusive clinical trials for diabetes among people with diabetes and their caregivers, Thank you, @nuhaaelsayed, for mentorship diabetesjournals.org/docm-care/arti…

@Anoodo We missed you out here 🌟

“Privilege to care and learn from our patients”

New—Clinical features, investigation, and management of Addison's disease thelancet.com/journals/landi… #adrenal insufficiency

The 2025 @AmThyroidAssn #thyroidcancer guidelines on systemic therapy. Drs. Gild, Brennan, @VenessaTsang review precision careemphasis, molecular profiling, timing & selection of targeted therapy. ow.ly/Hf9y50XVJtO #endotwitter #medtwitter #thyroid #lenvatinib #RET #NTRK

@sina_jasim @WashUDeptMed @TheAACE @AmThyroidAssn @NASITablate Great news!

@WashUDeptMed @TheAACE @AmThyroidAssn @NASITablate

New Voices of Wisdom: Dr. Zubair Baloch shares thyroid FNA pearls, what “adequate” really means, and where molecular testing and AI can help. voices-of-wisdom.podbean.com/?utm_campaign=… #ThyroidCytology #ThyroidCancer

@melina_manolas Is this like a medical platform Or something similar to linkedn?

So excited to be a part of this !

وَفِي السَّمَاء رِزْقُكُمْ وَمَا تُوعَدُونَ

Career milestone unlocked 🔓 Our case was published at #JCEM Case Reports by @TheEndoSociety Recurrent Orbital Metastases in Follicular Variant Papillary Thyroid Carcinoma After Recombinant Human Thyrotropin academic.oup.com/jcemcr/article…

🧠📢Check our recently published case report on Craniofacial and Rad Features as Diagnostic Clues to Unmask Acromegaly cureus.com/articles/43800…

Does the International Medullary Thyroid Carcinoma Grading System predict outcomes in metastatic MTC? A @ThyroidJournal study (France) validated IMTCGS—high-grade tumors (or Ki-67 ≥ 20%) had markedly shorter survival, confirming its prognostic value. ow.ly/VOsS50XGA66

Really enjoyed @TheAACE Clinical Guidance Forum Consensus Statement on Management of MEN1! Grateful to Drs. @sina_jasim, @JaydiDelRivero, and @AGangiMD for sharing the latest updates and expert insights. #Endocrinology #MEN1 #WeAreAACE

I don’t know about the product, but I liked the comic: finding the right data in the age of indefinite evidence—the modern challenge for every healthcare provider.